The action could lift shares of Kenvue, but Johnson & Johnson stock could come under pressure due to index selling.
Kenvue Inc. KVUE, +0.13%, the maker of Tylenol and Benadryl, will replace auto-parts retailer Advance Auto Parts Inc. AAP, -2.33% on the S&P 500 Index SPX, +0.69%, S&P Dow Jones Indices said on Monday
Kenvue (NYSE: KVUE ) stock is gaining modestly higher on Monday on the results of a share exchange with Johnson & Johnson (NYSE: JNJ ), from which Kenvue was spun off. Specifically, Johnson & Johnson
Citi (C) is considering a structure overall that would split its Institutional Clients Group into three separate business segments, according to a report from the Financial Times. The proposed move wo
Johnson & Johnson JNJ said Monday that 802.7 million shares of its common stock were validly tendered and not validly withdrawn in a Kenvue Inc. KVUE tender offer that expired at midnight Friday. The
Johnson & Johnson investors who elected to participate in the swap will see just 23.8% of their shares converted into Kenvue stock
Johnson & Johnson will split off its majority stake in Kenvue Inc. - current shareholders have until August 18 (Friday) to decide whether to exchange some or all of their Johnson & Johnson shares. In
Johnson & Johnson spinoff Kenvue will soon be added to the S&P 500. History has shown that stocks often enjoy a boost after the announcement of their addition to the S&P 500.
The $40 billion exchange offer for shares of Kenvue expires Friday but brokerage firms want retail investors to make their instructions before then

Is Kenvue Stock a Buy After Earnings?

08:55am, Friday, 11'th Aug 2023
Kenvue recently held its first earnings call as a standalone public company. While financial results are limited, the stock trades for a noticeable discount to its peers.

KVUE Stock Alert: Kenvue to Join the S&P 500

10:25am, Thursday, 10'th Aug 2023
Kenvue (NYSE: KVUE ) stock is a hot topic among traders on Thursday following news that it will be added to the S&P 500 . Investors will note that Kenvue is joining the S&P 500, as well as the S&P 100

J&J spinoff Kenvue set to join S&P 500 index

08:52am, Thursday, 10'th Aug 2023
Kenvue is set to make its debut in the S&P 500 index, a move confirmed by S&P Dow Jones Indices following the impending completion of Johnson and Johnson's exchange offer for Kenvue stock. The inclusi
The Johnson & Johnson spinoff is the consumer health company that makes Listerine and Tylenol.
Kenvue Inc., maker of Tylenol, Benadryl and other household names in health-care products, is joining the S&P 500, index provider S&P Dow Jones Indices said late Wednesday.
Johnson & Johnson ( JNJ , Financial) has recently announced its intention to split off Kenvue Inc. ( KVUE , Financial) shares through an exchange offer. This move marks the next step in the separation
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE